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Background: The prevalence of diabetes in China is increasing rapidly. However, scarce data are available on serum
electrolyte levels in Chinese adults with diabetes, especially in those with cardiovascular complications. This study
measured serum electrolyte levels and examined their relationship with macrovascular complications in Chinese
adults with diabetes.
Methods: The three gender- and age-matched groups were enrolled into this analysis, which were 1,170 subjects
with normal glucose regulation (NGR), 389 with impaired glucose regulation (IGR) and 343 with diabetes. Fasting
plasma glucose (FPG), 2-hour post-load plasma glucose (2hPG), glycosylated hemoglobin A1c (HbA1c) and serum
electrolyte levels were measured. Data collection included ankle brachial index results.
Results: Serum sodium and magnesium levels in the diabetes group were significantly decreased compared to the
NGR group (sodium: 141.0 ± 2.4 vs. 142.1 ± 2.0 mmol/l; magnesium: 0.88 ± 0.08 vs. 0.91 ± 0.07 mmol/l, all P < 0.01),
while the serum calcium level was significantly increased (2.36 ± 0.11 vs. 2.33 ± 0.09 mmol/l, P < 0.01). Multiple linear
regression showed that serum sodium and magnesium levels in the diabetes group were negatively correlated
with FPG, 2hPG and HbA1c (sodium: Std β = −0.35, -0.19, -0.25; magnesium: Std β = −0.29, -0.17, -0.34, all P < 0.01),
while the serum calcium level was positively correlated with HbA1c (Std β = 0.17, P < 0.05). In diabetic subjects,
serum sodium, magnesium and potassium levels were decreased in the subjects with the elevation of estimated
glomerular filtration rates (P < 0.05). ANCOVA analysis suggested that serum magnesium level in subjects with
diabetic macrovascular complications was significantly decreased compared with diabetic subjects without
macrovascular complications after the effect of some possible confounding being removed (P < 0.05).
Conclusions: Serum sodium and magnesium levels were decreased in Chinese subjects with diabetes, while the
observed increase in calcium level correlated with increasing glucose level. Diabetic patients with macrovascular
complications had lower serum magnesium level than those with no macrovascular complications.
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The electrolytes in serum include sodium (Na+),
potassium (K+), calcium (Ca2+) and magnesium (Mg2+)
[1]. These electrolytes play an important role in inter-
mediary metabolism and cellular function, including
enzyme activities and electrical gradients [2]. Serum
concentrations of electrolytes have been shown to change
with plasma glucose levels [3]. Disturbances in the levels
of some electrolytes are associated with diabetes mellitus
(DM) [4-7]. In addition, hypomagnesemia and diuretic-
associated hypokalemia may lead to a higher incidence of
DM [8,9], mild electrolyte changes such as low Mg2+
levels can predict mortality in type 2 DM [10] and oral
magnesium supplementation reduces fasting plasma glu-
cose levels in DM patients [11]. The Atherosclerosis
Risk in Communities (ARIC) study has shown an asso-
ciation between low serum magnesium level and an in-
creased risk of ischemic stroke in African Americans
and Caucasians [12].
The prevalence of DM in China is increasing rapidly
[13]. However, scant data are available on serum electro-
lyte levels in Chinese adults with diabetes, especially in
those with cardiovascular complications, such as cardio-
vascular disease (CVD) events and peripheral arterial
disease (PAD) [14]. In this study, we measured serum
electrolyte levels in Chinese subjects with diabetes, to in-
vestigate the relationship between electrolytes and glu-
cose levels, and we focus on examining the differences
in serum electrolytes in diabetic patients with or without
macrovascular complications.Figure 1 Flow diagram of subject recruitment.Methods
Study population
A gender- and age- matched case–control analysis was
performed based on data obtained from the follow-up
study of the Shanghai Diabetes Study (SHDS) and SHDS II
[15,16]. As shown in Figure 1, this follow-up study was
conducted from August 2010 to December 2011 in the
Caoyang, Anting, and Huayang communities in Shanghai,
China. Subjects enrolled in the analysis met the following
inclusion criteria: aged 20 years or above and under
75 years, with complete serum electrolytes and fasting glu-
cose data. Exclusion criteria included subjects once taking
diuretics in the 2 weeks before being interviewed (n = 21),
persistent diarrhea or vomiting (n = 0), severe renal insuffi-
ciency, which was determined using an estimated glomeru-
lar filtration rate (eGFR) <60 ml · min-1 · 1.73 m-2 (n = 34)
and any self-report of type 1 diabetes mellitus (T1DM) or
a history of diabetes of an unknown type (n = 39). In total,
2,723 subjects were enrolled in the study and were
grouped according to their glucose tolerance. They were
matched (the number ratio of subjects in each group
nearly 3:1:1) according to their gender and age (5-year in-
tervals). Then, a normal glucose regulation (NGR) group
(n = 1,170), an impaired glucose regulation (IGR) group
(n = 389) and a DM group (n = 343) were formed.
This study was approved by the institutional review
board of Shanghai Jiao Tong University Affiliated Sixth
People’s Hospital in accordance with the principle of the
Helsinki Declaration II. Written informed consent was
obtained from each subject before the survey.
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Subjects were invited to the local hospital between 6
and 8 am following an overnight 8–10 h fast. Venous
blood samples were collected at 0 and 120 min follow-
ing a 75-g oral glucose tolerance test (OGTT) for
subjects without self-reported diabetes, or after the con-
sumption of a steamed bun containing approximately
80 g of complex carbohydrates for subjects with self-
reported histories of DM. Fasting blood samples were
used to obtain serum electrolyte levels and other bio-
chemical analyses. Plasma glucose, electrolytes, creatin-
ine levels (SCr) and lipid profiles were determined with
an autoanalyzer (Hitachi 7600 analyzer, Hitachi, Japan).
The inter- and intra-assay coefficients of variation for Na+,
K+, Ca2+, Mg2+ were 0.77% and 1.13%; 1.01% and 1.22%;
1.80% and 3.00%; and 1.15% and 1.92% respectively.
Serum glycosylated hemoglobin (HbA1c) was mea-
sured using high-performance liquid chromatography. The
eGFR was assessed using the following formula: eGFR
(ml · min-1 · 1.73 m-2) = 186 × SCr (mg · dl-1)-1.154 × age-0.203
(for women × 0.742) [17].
Interviews and measurements
Demographic and disease history information was col-
lected again using a standardized questionnaire during
this follow-up study. The anthropometric indices of
height and weight were measured while subjects were
barefoot and wearing light clothing. The waist circum-
ference (WC) was measured at the point between the
costal margin and iliac crests. Body mass index (BMI)
was calculated as weight in kilograms divided by height
in meters squared [15]. A blood pressure measurement
was taken twice using a mercury sphygmomanometer
and the results averaged [18]. A Doppler probe (Nicolet
VersaLab SE) was used to calculate the ankle brachial
index (ABI), which is equal to the highest measured ar-
terial pressure in the ankle or foot divided the pressure
in the arm on each side [19].
Definitions and diagnostic criteria
DM was defined as a fasting plasma glucose (FPG) ≥
7.0 mmol/l and/or a 2-hour post-load plasma glucose
(2hPG) ≥11.1 mmol/l, or on diabetic medication treatment
for type 2 diabetes (T2DM). IGR was defined by an im-
paired fasting glucose (6.1 mmol/l < FPG <7.0 mmol/l and
2hPG <7.8 mmol/l), impaired glucose tolerance (FPG <
6.1 mmol/l and 7.8 mmol/l < 2hPG < 11.1 mmol/l), and
impaired fasting glucose with impaired glucose tolerance
(6.1 mmol/l < FPG <7.0 mmol/l and 7.8 mmol/l < 2hPG <
11.1 mmol/l) in the follow-up [20]. Normal serum
electrolyte reference ranges were used as follows:
137 mmol/l ≤Na+ ≤ 145 mmol/l, 3.5 mmol/l ≤ K+ ≤
5.1 mmol/l, 2.08 mmol/l ≤Ca2+ ≤ 2.60 mmol/l, 0.65 mmol/
l ≤Mg2+ ≤ 1.05 mmol/l. Hypertension was defined as ablood pressure of >140/90 mmHg or the use of antihyper-
tensive medications [21]. Dyslipidemia was defined as a
serum triglyceride (TG) level ≥1.7 mmol/L or a high dens-
ity lipoprotein cholesterol (HDL-C) level <0.9 mmol/L in
men and <1.0 mmol/L in women [22].
Diabetic macrovascular complications in this study in-
cluded any patient with a history of CVD events or PAD.
Subjects were defined as having had CVD events if a his-
tory of coronary heart disease (CHD) or stroke was evi-
dent. Various non-fatal CVDs were determined according
to the self-reports of patients, which were confirmed by
their medical records. The definition of CHD included a
history of hospitalization for myocardial infarction, a surgi-
cal history of coronary balloon angioplasty, coronary stent
implantation or coronary artery bypass. Stroke was defined
as a history of language or physical dysfunction that contin-
ued for more than 24 h, and ischemic or hemorrhagic
stroke was diagnosed using imaging examinations (com-
puted tomography or magnetic resonance imaging) [23].
According to the current guidelines proposed by the
American Heart Association (AHA), PAD was identified
as an ABI <0.90 in either leg. Those with an ABI >1.3 were
excluded from the analysis to avoid those with significant
medial artery layer calcification, which is independent of
atherosclerotic plaques [24]; other individuals were con-
sidered as non-PAD [19].
Statistical methods
Summarized data are shown as mean ± standard devi-
ation or as frequencies (%). One-way analysis of variance
(one-way ANOVA) was used to compare the mean dif-
ferences and the Pearson’s chi-square test was used to
compare the proportional differences in demographic
characteristics and serum electrolyte levels among the
NGR, IGR and DM groups, or among the mildly de-
creased eGFR, normal eGFR and elevated eGFR groups.
The linear trends of electrolyte levels within the groups
were tested. Multiple linear regression analyses were
used to determine the relationships between electrolytes
and glucose levels. Analysis of covariance (ANCOVA)
was used to compare the mean differences in electrolyte
levels after adjustment by possible confounding factors
between DM subjects with macrovascular complications
and those without macrovascular complications. SPSS
for windows (version 17.0, SPSS, Chicago, IL, USA) was
used to perform the statistical analyses. The significance
level was P value <0.05, and the results were adjusted
with the Bonferroni correction for multiple testing.
Results
Characteristics of the study population
The gender and age distributions of all subjects prior to
matching, and of the remaining unmatched subjects
were shown in Table 1. After matching, an overall total
Table 1 Gender and age distributions of all subjects prior
to matching, and those of the unmatched and matched
subjects
NGR (Group I) IGR (Group II) DM (Group III)
Before matching
n (men/women) 1768 (623/1145) 524 (184/340) 431 (182/249)
Age (years) 52.6 ± 11.5 57.2 ± 10.2 60.0 ± 9.2
Unmatched
n (men/women) 598 (165/433) 135 (31/104) 88 (35/53)
Age (years) 43.8 ± 11.1 56.5 ± 12.8 67.2 ± 7.4
Matched
n (men/women) 1170 (458/712) 389 (153/236) 343 (147/196)
Age (years) 57.1 ± 8.7 57.5 ± 9.1 58.1 ± 8.6
Descriptive values are expressed as the frequency or
mean ± standard deviation.
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age of 57.4 ± 8.8 years participated in this study. As
shown in Table 2, among the NGR, IGR and DM
groups, there were no significant differences in gender
or age. There were significant differences in BMI, WC,
systolic blood pressure (SBP), diastolic blood pressure








Age (years) 57.1 ± 8.7 57.5 ± 9.1
BMI (Kg · m-2) 23.3 ± 3.6 24.6 ± 3.5
WC (cm) 81.1 ± 9.4 84.8 ± 9.2
SBP (mmHg) 124 ± 16 129 ± 18
DBP (mmHg) 79 ± 10 81 ± 10
TC (mmol/L) 5.17 ± 0.95 5.32 ± 0.97 5
TG (mmol · L-1) 1.45 ± 1.02 1.79 ± 1.17 2
HDL-C (mmol · L-1) 1.44 ± 0.34 1.34 ± 0.31 1
SCr (umol · L-1) 66.0 ± 12.7 65.5 ± 13.8 6
eGFR (ml · min-1 · 1.73 m-2) 99.4 ± 16.9 100.9 ± 18.6 1
FPG (mmol · L-1) 5.22 ± 0.45 5.85 ± 0.61 8
2hPG (mmol · L-1) 5.77 ± 1.11 8.15 ± 1.50 1
HbA1c (%) 5.5 ± 0.4 5.7 ± 0.5
Hypertension (%) 462 (39.5) 212 (54.5)
Dyslipidemia (%) 305 (26.1) 160 (41.1)
CVD (%) 66 (5.6) 34 (8.7)
PAD (%) 38 (3.3) 19 (4.9)
Descriptive values are expressed as the mean ± standard deviation or frequency (%
the chi-square test for proportions. The Bonferroni correction is applied for the mul
Abbreviations: NGR Normal glucose regulation, IGR Impaired glucose regulation, DM
blood pressure, DBP Diastolic blood pressure, PAD Peripheral arterial disease, TC Tot
Fasting plasma glucose, 2hPG 2-hour post-load plasma glucose, HbA1c GlycosylatedFPG, 2hPG, and HbA1c. In the DM group, 231 (65.3%)
subjects had hypertension, 173 (48.9%) had dyslipidemia
and 37 (10.5%) had a history of CVD events. These pro-
portions were significantly higher in the DM group than
in the NGR group. There was no significance in the pro-
portion of individuals affected by PAD among the three
groups.
The study included 343 subjects with diabetes (147
men, 196 women) with a mean age of 58.1 ± 8.6 years.
There were 178 self-reported T2DM subjects (80 men,
98 women) in them. In the self-reported T2DM subjects,
the mean diabetes duration was 9.1 ± 6.2 years and 31
(17.4%) subjects claimed to be currently receiving insulin
therapy. Medications that were taken at the time of the
study by individuals in the NGR, IGR and DM groups
were also shown in Table 3.
Serum electrolyte levels among the three groups
Among the NGR, IGR and DM groups, 9 (0.8%), 4 (1.0%)
and 14 (4.1%) subjects had hyponatremia (P < 0.01), while
55 (4.7%), 17 (4.4%), and 10 (2.9%) subjects had
hypernatremia (P = 0.36); 14 (1.2%), 11 (2.8%) and 2 (0.6%)
had hypokalemia (P = 0.02), while 17 (1.5%), 3 (0.5%) and
4 (1.2%) subjects had hyperkalemia (P = 0.57); 6 (0.5%),





All I vs. II II vs. III I vs. III
58.1 ± 8.6 0.19 1.000 1.000 0.216
25.2 ± 4.0 <0.01 <0.001 0.120 <0.001
86.8 ± 9.1 <0.01 <0.001 0.011 <0.001
132 ± 17 <0.01 <0.001 0.017 <0.001
83 ± 9 <0.01 0.028 0.015 <0.001
.39 ± 1.00 <0.01 0.028 0.956 0.001
.15 ± 2.04 <0.01 <0.001 <0.001 <0.001
.27 ± 0.29 <0.01 <0.001 0.011 <0.001
4.0 ± 14.8 0.04 1.000 0.371 0.041
05.6 ± 22.4 <0.01 0.515 0.002 <0.001
.30 ± 2.62 <0.01 <0.001 <0.001 <0.001
4.63 ± 5.03 <0.01 <0.001 <0.001 <0.001
7.2 ± 1.6 <0.01 <0.001 <0.001 <0.001
231 (65.3) <0.01 <0.001 0.003 <0.001
173 (48.9) <0.01 <0.001 0.033 <0.001
37 (10.5) <0.01 0.031 0.350 0.001
15 (4.2) 0.23 0.323 0.334 0.150
). Differences are assessed using the one-way ANOVA test for means and by
tiple testing.
Diabetes mellitus, BMI Body mass index, WC Waist circumstance, SBP Systolic
al cholesterol, TG Triglyceride, HDL High density lipoprotein cholesterol, FPG
hemoglobin.
Table 3 Current medication among the groups







Diuretic (%) 0 (0.0) 0 (0.0) 0 (0.0)
ARB (%) 77 (6.6) 25 (6.4) 46 (13.4)
ACEI (%) 27 (2.3) 16 (4.1) 23 (6.7)
β-blocker (%) 12 (1.0) 10 (2.6) 5 (1.5)
CCB (%) 86 (7.4) 53 (13.6) 59 (17.2)
Others (%) 36 (3.1) 24 (6.2) 10 (2.9)
Antidiabetic drugs Self-reported
T2DM(n = 178)
Insulin (%) 31 (17.4)
Oral hypoglycemic drugs
Metformin (%) 61 (34.3)
Sulphonylurea (%) 41 (23.0)
Glinide (%) 26 (14.6)
Thiazolidinedione (%) 10 (5.6)
α-Glucosidase inhibitor (%) 24 (13.5)
Others (%) 3 (1.7)
Descriptive values are expressed as frequency (%).
Abbreviations: ARB Angiotensin II receptor blocker, ACEI Angiotensin-converting
enzyme inhibitor, CCB Calcium channel blocker.
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(P = 0.09); 0 (0.0%), 0 (0.0%) and 2 (0.6%) had hypomag-
nesemia (P = 0.01), while 26 (2.2%), 11 (2.8%) and 3 (0.9%)
subjects had hypermagnesemia (P = 0.16).
As shown in Table 4, when compared to the NGR
group, serum levels of Na+ and Mg2+ were significantly
decreased (P < 0.01), while Ca2+ level was significantly
increased for both genders in the DM group (P < 0.01).
Serum Na+, Mg2+ and Ca2+ levels showed linear trends
in the DM, IGR and NGR groups (P < 0.01).
Serum electrolyte levels in DM subjects with different
eGFRs
As shown in Table 5, DM subjects were divided into mildly
decreased eGFR (eGFR 60 to 89 ml · min- · 1.73 m-2), nor-
mal eGFR (eGFR 90 to 119 ml · min- · 1.73 m-2) and ele-
vated eGFR groups (eGFR over 120 ml · min- · 1.73 m-2).
Serum Na+, Mg2+ and K+ levels were lowest in the elevated
eGFR group (P < 0.01) and showed decreasing trends from
the mildly decreased eGFR group, normal eGFR group to
the elevated eGFR group (P < 0.01).
Correlation of electrolytes and glucose levels in subjects
with DM
As shown in Table 6, serum Na+ and Mg2+ levels were
negatively correlated with FPG (Pearson’s r = −0.35
and −0.29, respectively), 2hPG (Pearson’s r =−0.19 and −0.17,respectively) and HbA1c (Pearson’s r = −0.25 and −0.34,
respectively; all P < 0.01), while serum Ca2+ level was posi-
tively correlated with HbA1c (Pearson’s r = 0.17; P < 0.05)
after adjustment for co-variables, including gender, age,
BMI, SBP, DBP, TG, HDL and eGFR levels.
Serum electrolyte levels in subjects with and without DM
macrovascular complications
As shown in Table 7, only serum Mg2+ level was signifi-
cantly lower in DM subjects with macrovascular com-
plications compared to those without macrovascular
complications. The mean value of serum Mg2+ level was
0.86 ± 0.10 mmol/L and 0.87 ± 0.08 mmol/L, respectively
(P < 0.05). In detail, the mean value of serum Mg2+ level
was 0.85 ± 0.11 mmol/L and 0.88 ± 0.08 mmol/L in sub-
jects with and without CVD events, respectively, and
0.85 ± 0.10 mmol/L and 0.87 ± 0.08 mmol/L in subjects
with and without PAD, respectively.
Discussion
Derangement of water and electrolyte balances may
occur in subjects with DM, resulting from insulin defi-
ciency, hyperglycemia and hyperketonemia [25]. The
present study has determined that electrolyte levels are
altered among Chinese subjects with different glucose
tolerance statuses. Specifically, we verified that serum
Mg2+ level was reduced in Chinese subjects with diabetic
macrovascular complications.
Alterations in serum electrolyte levels with elevated
glucose levels
Significant reductions in serum Na+ and Mg2+ levels and
an elevation in serum Ca2+ in subjects with DM were
observed. These results were consistent with those
reported by previous studies [6,7,26,27]. Furthermore,
levels of serum Na+ and Mg2+ were negatively correlated
with plasma glucose levels, measured as FPG, 2hPG and
HbA1c, while Ca2+ level was positively correlated with
HbA1c in subjects with DM.
Previous studies have estimated that serum Na+ con-
centrations decrease from 0.24 mmol/l to 0.29 mmol/l
for every 1.0 mmol/l decrease in glucose concentration
[28,29]. Our findings suggested there was a 0.32 mmol/l
decrease of Na+ per 1.0 mmol/l fasting plasma glucose.
Yajnik et al. observed that plasma Mg2+ concentrations
were inversely related to plasma glucose levels in sub-
jects with DM [30], and our results are in accordance
with this.
In the present study, serum electrolyte levels of Na+
and Mg2+ decreased along with an elevation in the eGFR
in subjects with DM. Under physiological conditions,
most of the Na+ is reabsorbed in the proximal tubule of
the kidney and Mg2+ is mostly reabsorbed in the loop of
Henle [31]. Hyperglycemia-induced osmotic diuresis,










All I vs. II II vs. III I vs. III Linear trend
Overall n = 1170 n = 389 n = 343
Na+ (mmol/L) 142.1 ± 2.0 142.1 ± 2.0 141.0 ± 2.4 <0.01 1.000 <0.001 <0.001 <0.01
K+ (mmol/L) 4.21 ± 0.37 4.17 ± 0.38 4.26 ± 0.37 0.01 0.188 0.007 0.172 0.25
Ca2+ (mmol/L) 2.33 ± 0.09 2.34 ± 0.09 2.36 ± 0.11 <0.01 0.110 0.034 <0.001 <0.01
Mg2+ (mmol/L) 0.91 ± 0.07 0.92 ± 0.08 0.88 ± 0.08 <0.01 0.643 <0.001 <0.001 <0.01
Men n = 458 n = 153 n = 147
Na+ (mmol/L) 142.0 ± 2.0 142.3 ± 1.9 141.0 ± 2.2 <0.01 0.501 <0.001 <0.001 <0.01
K+ (mmol/L) 4.22 ± 0.39 4.14 ± 0.38 4.26 ± 0.40 0.04 0.128 0.040 0.930 0.71
Ca2+ (mmol/L) 2.32 ± 0.09 2.32 ± 0.09 2.34 ± 0.10 <0.01 1.000 0.121 0.002 <0.01
Mg2+ (mmol/L) 0.92 ± 0.07 0.92 ± 0.08 0.89 ± 0.08 <0.01 1.000 <0.001 <0.001 <0.01
Women n = 712 n = 236 n = 196
Na+ (mmol/L) 142.1 ± 2.0 141.9 ± 2.1 141.1 ± 2.5 <0.01 1.000 <0.001 <0.001 <0.01
K+ (mmol/L) 4.21 ± 0.36 4.19 ± 0.37 4.26 ± 0.34 0.14 1.000 0.169 0.309 0.22
Ca2+ (mmol/L) 2.34 ± 0.09 2.35 ± 0.09 2.37 ± 0.11 <0.01 0.143 0.217 0.001 <0.01
Mg2+ (mmol/L) 0.91 ± 0.07 0.92 ± 0.08 0.87 ± 0.09 <0.01 1.000 <0.001 <0.001 <0.01
Descriptive values are expressed as the mean ± standard deviation. Differences are assessed using the one-way ANOVA. Bonferroni correction is applied for
multiple testing. Linear trends of electrolyte levels within groups were tested.
Abbreviations: NGR Normal glucose regulation, IGR Impaired glucose regulation, DM Diabetes mellitus, Na Sodium, K Potassium, Ca Calcium, Mg, Magnesium.
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mechanism underlying the decreased serum concentra-
tions of Na+ and Mg2+ observed in response to elevated
glucose levels. Additionally, overly aggressive volume re-
expansion and glomerular hyperfiltration can induce
renal Mg2+ wasting at the proximal tubule and the loop
of Henle. Mg2+ reabsorption parallels Na+ reabsorption
in the proximal tubules; therefore, volume expansion
would further decrease the reabsorption of both Mg2+
and Na+ [8,32].
In addition, we found that serum Ca2+ level was posi-
tively correlated with glucose level. This observation was
consistent with previous studies [27,33,34]. Ca2+ is mainly
reabsorbed in the proximal tubule. Its reabsorption is
coupled to Na+ absorption, and it appears to compete with
Mg2+ for transport in the loop of Henle. In the distalTable 5 Serum electrolyte levels in DM subjects stratified by
Electrolyte
levels
eGFR (ml · min- · 1.73 m-2)
Mildly decreased
(Group I) (n = 81)
Normal
(Group II)(n = 186)
El
(Group
Na+ (mmol/L) 141.8 ± 2.1 141.1 ± 2.5 14
K+ (mmol/L) 4.36 ± 0.38 4.23 ± 0.36 4.2
Ca2+ (mmol/L) 2.36 ± 0.11 2.35 ± 0.11 2.3
Mg2+ (mmol/L) 0.90 ± 0.08 0.88 ± 0.08 0.8
Descriptive values are expressed as the mean ± standard deviation. Differences are
testing. Linear trends of electrolyte levels within groups were tested.
Abbreviations: eGFR Estimated glomerular filtration rate, NGR Normal glucose regula
Potassium, Ca Calcium, Mg Magnesium.convoluted tubule, Ca2+ absorption is regulated independ-
ently of Na+, where numerous factors, such as calcitonin,
parathyroid hormone, and vitamin D, can have marked ef-
fects on Ca2+ reabsorption and secretion [31,35]. Energy
metabolism is associated with bone remodeling, and glu-
cose levels also regulate parathyroid hormone and vitamin
D levels [36]. This means that the excess excretion of Ca2
+, induced by hyperglycemia, may be weakened by several
pathways. Alternatively, the Resnick ionic hypothesis sug-
gested that metabolic disorders, such as hypertension,
metabolic syndrome, and diabetes, share a common, al-
tered intracellular condition, characterized by decreased
Mg2+ level and reciprocally elevated free intracellular Ca2+
level [37]. Intracellular Ca2+ plays a critical role in muscle
contractions, insulin secretion, and glucose uptake after
the binding of insulin to muscle cell membranes. TheeGFR.
P-value
evated
III) (n = 76)
All I vs. II II vs. III I vs. III Linear
trend
0.1 ± 2.1 <0.01 0.114 0.006 <0.001 <0.01
2 ± 0.35 0.02 0.022 1.000 0.052 0.02
6 ± 0.09 0.82 1.000 1.000 1.000 0.90
4 ± 0.10 <0.01 0.308 0.003 <0.001 <0.01
assessed using one-way ANOVA. Bonferroni correction is applied for multiple
tion, IGR Impaired glucose regulation, DM Diabetes mellitus, Na Sodium, K
Table 6 Multiple linear regression analyses of the associations between electrolyte levels and glucose levels in DM
subjects
Dependent variables Independent variables Std β β SE P-value R2
Na+ FPG (mmol/L) −0.35 −0.319 0.049 <0.01 0.23
(mmol/L) 2hPG (mmol/L) −0.19 −0.093 0.026 <0.01 0.16
HbA1c (%) −0.25 −0.386 0.086 <0.01 0.18
K+ FPG (mmol/L) 0.01 0.001 0.008 0.99 0.04
(mmol/L) 2hPG (mmol/L) 0.03 0.002 0.004 0.63 0.04
HbA1c (%) 0.08 0.018 0.014 0.21 0.05
Ca2+ FPG (mmol/L) 0.11 0.004 0.002 0.07 0.04
(mmol/L) 2hPG (mmol/L) 0.09 0.002 0.001 0.14 0.04
HbA1c (%) 0.17 0.011 0.004 <0.01 0.06
Mg2+ FPG (mmol/L) −0.29 −0.009 0.002 <0.01 0.17
(mmol/L) 2hPG (mmol/L) −0.17 −0.003 0.001 <0.01 0.13
HbA1c (%) −0.34 −0.018 0.003 <0.01 0.20
Linear regression analysis, where electrolyte levels is used as the dependent variable, FPG, 2hPG, HbA1c are the independent variables, and gender, age, BMI, SBP,
DBP, TG, HDL and eGFR levels are the co-variables, using the Enter method.
Abbreviations: FPG Fasting plasma glucose, 2hPG 2-hour post-load plasma glucose, HbA1c Glycosylated hemoglobin, Na Sodium, K Potassium, Ca Calcium,
Mg Magnesium.
Table 7 Serum electrolyte levels in DM subjects with and
without macrovascular complications
Electrolyte levels Subgroups P-value
Non-CVD CVD
(n = 306) (n = 37)
Na+ (mmol/L) 141.1 ± 2.4 140.9 ± 2.6 0.317
K+ (mmol/L) 4.25 ± 0.37 4.34 ± 0.36 0.346
Ca2+ (mmol/L) 2.36 ± 0.11 2.37 ± 0.09 0.768
Mg2+ (mmol/L) 0.88 ± 0.08 0.85 ± 0.11 0.004
Non-PAD PAD
(n = 271) (n = 15)
Na+ (mmol/L) 141.1 ± 2.3 140.7 ± 3.2 0.094
K+ (mmol/L) 4.25 ± 0.37 4.21 ± 0.25 0.579
Ca2+ (mmol/L) 2.36 ± 0.10 2.33 ± 0.11 0.417





(n = 243) (n = 50)
Na+ (mmol/L) 141.0 ± 2.3 141.0 ± 2.8 0.221
K+ (mmol/L) 4.24 ± 0.37 4.31 ± 0.34 0.555
Ca2+ (mmol/L) 2.36 ± 0.11 2.35 ± 0.10 0.667
Mg2+ (mmol/L) 0.87 ± 0.08 0.86 ± 0.10 0.017
Descriptive values are expressed as the mean ± standard deviation. Differences
are assessed using ANCOVA, adjusted for age, gender, BMI, WC, hypertension
and dyslipidemia.
Abbreviations: CVD Cardiovascular disease, PAD Peripheral artery disease, Na
Sodium, K Potassium, Ca Calcium, Mg Magnesium.
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sulin resistance, which mostly occurs in skeletal muscle,
and the impairment of insulin secretion [38]. All these fac-
tors may account for the elevation of serum Ca2+ level in
subjects with DM, and especially in patients whose eGFR
levels are increased.
Furthermore, it has been observed that cellular mem-
brane electrolyte transporter Na+-K+-ATPase dysfunction
in diabetic subjects, can be secondary to hyperglycemia
[39]. And the functions of Ca2+-Mg2+-ATPase, Na+/Ca2+
exchanger and Ca2+ pump, which are located in cell mem-
brane, mitochondria or endoplasmic reticulum, have been
shown to be impaired in diabetes [40,41]. Electrolyte dis-
turbances within cells can be induced by them above men-
tioned. The combination of intracellular and extracellular
electrolyte disturbances may be implicated in the patho-
genesis of neuropathy, nephropathy and vascular compli-
cations in diabetic patients.
Serum Mg2+ level is further decreased in subjects with
diabetic macrovascular complications
We found that serum Mg2+ level was reduced in subjects
with diabetic macrovascular complications. Ma et al. also
demonstrated that, in African Americans and Caucasians,
serum Mg2+ level was significantly lower in subjects with
prevalent CVD and diabetes [42]. Recently, Larsson et al.
performed a meta-analysis based on eight prospective
studies and concluded that there was a significant inverse
relationship between dietary Mg2+ intake and stroke risk
[43]. It has also been observed that serum Mg2+ depletion
is associated with some PAD symptoms, such as foot ul-
cers, in subjects with type 2 DM [44]. In addition, Resnick
ionic hypothesis suggested that the intracellular Mg2+ level
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a common cellular defect in ion handling in various
clinical manifestations of metabolic disorders [37]. Both
decreased intracellular and extracellular Mg2+ concen-
trations may accelerate atherogenesis via the elevation
of inflammatory cytokines and lipid oxidation, an in-
crease in endothelial cell growth and the inhibition of
cellular DNA repair [45-48].
Diabetic macrovascular complications, CVD in par-
ticular, are currently the leading cause of death for dia-
betic patients. It has been reported that even low Mg2+
levels that are still within the normal reference range are
associated with all-cause mortality in patients with
T2DM [10]. Our results would raise awareness of physi-
cians, especially in China, and allow them to promptly
correct mild electrolyte disturbances in diabetic patients.
Even though many observational studies of electrolyte
disturbances in patients with diabetes have consistently
report that Mg2+ intervention may be extremely useful
in the prevention and treatment of the cardiometabolic
syndrome [49], some results of intervention studies, es-
pecially those involving daily electrolyte supplements for
the prevention of DM or against diabetic complications,
are controversial [50].
Strengths and limitations
The first strength was that our subjects were from a
large population-based survey. The symptoms and com-
plications of the diabetes group were relatively mild, and
the effects of iatrogenic factors on electrolytes were less
than in those patients who were administrated in hos-
pital. Secondly, we matched subjects among the NGR,
IGR and DM groups to reduce the significant differences
in gender and age distribution. A main limitation of our
study was that we only measured the total serum elec-
trolytes levels, but not free ionized or intracellular elec-
trolytes or levels in other biological samples from the
subjects [51], which need some special apparatus to
measure [52]. Although questionnaire data are of great
value in collecting the information of the history of non-
fatal CVDs, misclassification remains a possibility [53].
Moreover, even though the analyses were adjusted for
the common risk factors of age, gender, obesity, hyper-
tension and dyslipidemia, unmeasured factors, such as
eating habits and other medications, may have indirect
effects on the electrolyte regulation and interfere with
the relationship between CVD and electrolyte distur-
bances. Our study also did not elucidate the causal rela-
tionship of serum electrolyte levels on the development
of DM and diabetic macrovascular complications.
Conclusions
Our study advances our knowledge of electrolytes levels in
Chinese subjects with diabetes that these subjects havedecreased Na+ and Mg2+ and increased Ca2+ levels com-
pared to normal subjects. These alterations in electrolyte
levels may underlie many of the pathophysiologic and
clinical characteristics of diabetes. Furthermore, signifi-
cant negative associations were found between serum
Na+, Mg2+ levels and glucose level respectively, while
Ca2+ level was positively associated with glucose level.
Of more importance, the subjects with lower serum
Mg2+ level had an increased likelihood of diabetic
macrovascular complications.
Abbreviations
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